院前床旁肌钙蛋白对疑似NSTE-ACS风险分层的个体患者数据荟萃分析
低风险分层预测30天全因死亡的敏感度93.2%、阴性预测值99.8%,预测死亡和/或AMI及MACE的敏感度与NPV亦较高;降低低风险 cutoff 可提高敏感度与NPV但减少低风险患者比例。
要点
- HEART衍生风险评分在训练有素的EMS系统中可有效识别30天死亡和MACE极低风险患者。
- 低风险分层对30天全因死亡的敏感度93.2%、NPV 99.8%。
- 在其他医疗体系实施前需额外验证,因医疗结构、分层流程和随访能力存在差异。
核心结论
- 在训练有素的EMS系统中,HEART衍生临床风险评分能有效识别30天死亡和MACE风险极低的疑似NSTE-ACS患者。
- 在其他医疗体系实施需额外验证,因医疗结构、风险分层流程和随访能力存在差异。
研究设计与样本
- 系统评价与个体患者数据荟萃分析,纳入在EMS环境中使用临床风险评分或床旁肌钙蛋白对疑似NSTE-ACS患者进行风险分层的前瞻性研究。
主要发现
- 低风险临床风险评分预测30天全因死亡的敏感度为93.2%(83.5-98.1),NPV为99.8%(99.5-99.9)。
- 预测30天死亡和/或AMI的敏感度为91.8%(83.0-96.2),NPV为97.3%(89.9-99.3)。
- 预测30天MACE的敏感度为92.8%(88.7-95.5),NPV为97.2%(92.1-99.0)。
- 降低识别低风险患者的临床风险评分 cutoff 值可提高敏感度和NPV,但减少被归类为低风险的患者比例。
关键数值与推荐
- 低风险定义基于临床风险评分或床旁肌钙蛋白测量。
- 评估的安全性是低风险患者30天内全因死亡、死亡和/或AMI复合终点、MACE的敏感度和阴性预测值。
临床怎么用
- 在训练有素且能对低风险患者进行及时准确随访的EMS系统中,可使用HEART衍生临床风险评分进行院前风险分层。
- 在其他医疗体系应用前,需考虑医疗结构、风险分层流程和随访能力的差异并进行额外验证。
局限性
- 纳入研究均使用HEART评分衍生的临床风险评分,其他评分的证据有限。
- 实施于其他医疗体系需额外验证,因医疗结构、风险分层流程和随访能力存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emergency Medical Services (EMS) patients with chest pain are often suspected of having non-ST-elevation acute coronary syndrome (NSTE-ACS). Current risk stratification protocols for NSTE-ACS have limitations, leading to a lack of a well-organised prehospital diagnostic pathway. Recent studies have demonstrated that using clinical risk scores (CRS) including point-of-care (POC)-troponin in the EMS can improve prehospital diagnostic pathways for suspected NSTE-ACS. The primary aim of this systematic review and individual patient data meta-analysis was to assess safety of low-risk stratification for suspected NSTE-ACS patients in the prehospital setting. METHODS: Prospective studies using CRS or POC-troponin for risk stratification in suspected NSTE-ACS patients within the EMS setting were included. Safety was assessed using sensitivity and negative predictive value (NPV) for patients identified as low risk, based on CRS or POC-troponin measurement, for three different endpoints within 30 days: (1) all-cause mortality, (2) composite of mortality and/or acute myocardial infarction (AMI), (3) major adverse cardiac events (MACE). RESULTS: Of 1526 articles screened, 6 were included, comprising 5.239 patients, and all utilised CRS derived from the History, ECG, Age, Risk-factor and Troponin (HEART) score. The summary of low-risk CRS diagnostic performance predicted all-cause mortality with a sensitivity of 93.2% (83.5-98.1) and NPV of 99.8% (99.5-99.9); mortality and/or AMI with a sensitivity of 91.8% (83.0-96.2) and an NPV of 97.3% (89.9-99.3); and MACE with a sensitivity of 92.8% (88.7-95.5) and an NPV of 97.2% (92.1-99.0). Lowering the CRS cut-off value for identifying low-risk patients increased sensitivity and NPV but decreased the proportion of patients classified as low risk. CONCLUSION: In well-trained EMS systems, where prompt and accurate follow-up of low-risk patients is possible, HEART-derived CRS effectively identify patients with a very low risk of 30-day mortality and MACE. However, implementation in other healthcare systems requires additional validation, given the variations in healthcare structure, risk stratification processes and follow-up capabilities.
引用
- Demandt, Sagel, Camaro, et al. Prehospital risk stratification in suspected non-ST-segment elevation acute coronary syndrome with point-of-care troponin: an individual patient data meta-analysis. Heart. 2026. PMID: 41482474. doi:10.1136/heartjnl-2025-326922
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。